Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank67
Studio
Year-over-Year Change

Return on equity

Percentile
P67
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-16.57%+49.2%
2024-32.61%+56.8%
2023-75.51%-88.9%
2022-39.98%-87.8%
2021-21.28%-128.9%
202073.63%+11.6%
201965.99%-